Table 2

- Distribution of transfusion-transmissible infection markers among blood donors according to ABO blood type.

MarkersABABOP-values
HIV
Positive9 (0.3)0 (0.0)0 (0.0)5 (0.1)0.137*
Negative3302 (99.7)967 (100)264 (100)5548 (99.9)
HBsAg
Positive13 (0.4)4 (0.4)5 (1.9)15 (0.3)X2=18.40
Negative3298 (99.6)963 (99.6)259 (98.1)5538 (99.8)0.0004**
HBcAb
Positive142 (4.3)52 (5.4)11 (4.2)238 (4.3)X2=2.503
Negative3169 (95.7)915 (94.6)253 (95.8)5315 (95.7)0.47**
Malaria
Positive4 (0.1)0 (0.0)0 (0.0)1 (0.0)0.23*
Negative3307 (100)967 (100)264 (100)5552 (100)
HTLV
Positive2 (0.1)0 (0.0)0 (0.0)0 (0.0)0.33*
Negative3309 (99.9)967 (100)264 (100)5553 (100)
HCV
Positive16 (0.5)5 (0.5)1 (0.4)21 (0.4)X2=0.7582
Negative3295 (99.5)962 (99.5)263 (99.6)5532 (99.7)0.85**
Syphilis
Positive19 (0.6)4 (0.4)0 (0.0)22 (0.4)0.54*
Negative3292 (99.4)963 (99.6)264 (100)5531 (99.6)
HBV
Positive11 (0.3)3 (0.3)4 (1.5)14 (0.3)X2=12.76
Negative3300 (9.7)964 (99.7)260 (98.5)5539 (99.7)0.005**
HCV
Positive0 (0.0)1 (0.1)0 (0.0)2 (0.0)0.25*
Negative3311 (100)966 (99.9)264 (100)5551 (99.9)
HIV
Positive5 (0.1)0 (0.0)0 (0.0)4 (0.1)0.56*
Negative3306 (99.8)967 (100)264 (100)5549 (99.9)

Values are presented as numbers and percentages (%).

HIV: human immunodeficiency virus, HBsAg: hepatitis B surface antigen, HBcAb: hepatitis B core antibody, HTLV: human T-lymphotropic virus, HCV: hepatitis C virus, HBV: hepatitis B virus, NAT: nucleic acid test

  • * Fisher exact test.

  • ** Chi-square test.